Nuvation Bio (NUVB) Receivables - Other (2023 - 2025)
Nuvation Bio (NUVB) has disclosed Receivables - Other for 3 consecutive years, with $3.3 million as the latest value for Q4 2025.
- On a quarterly basis, Receivables - Other fell 7.98% to $3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.3 million, a 7.98% decrease, with the full-year FY2025 number at $3.3 million, down 7.98% from a year prior.
- Receivables - Other was $3.3 million for Q4 2025 at Nuvation Bio, down from $5.5 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $5.5 million in Q3 2025 to a low of $2.3 million in Q1 2023.
- A 3-year average of $3.8 million and a median of $3.8 million in 2023 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: surged 88.43% in 2024, then dropped 7.98% in 2025.
- Nuvation Bio's Receivables - Other stood at $3.7 million in 2023, then fell by 3.57% to $3.6 million in 2024, then dropped by 7.98% to $3.3 million in 2025.
- Per Business Quant, the three most recent readings for NUVB's Receivables - Other are $3.3 million (Q4 2025), $5.5 million (Q3 2025), and $4.0 million (Q2 2025).